GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Fukuda Denshi Co Ltd (TSE:6960) » Definitions » COGS-to-Revenue

Fukuda Denshi Co (TSE:6960) COGS-to-Revenue : 0.48 (As of Dec. 2023)


View and export this data going back to 1982. Start your Free Trial

What is Fukuda Denshi Co COGS-to-Revenue?

Fukuda Denshi Co's Cost of Goods Sold for the three months ended in Dec. 2023 was 円15,798 Mil. Its Revenue for the three months ended in Dec. 2023 was 円32,717 Mil.

Fukuda Denshi Co's COGS to Revenue for the three months ended in Dec. 2023 was 0.48.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Fukuda Denshi Co's Gross Margin % for the three months ended in Dec. 2023 was 51.71%.


Fukuda Denshi Co COGS-to-Revenue Historical Data

The historical data trend for Fukuda Denshi Co's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fukuda Denshi Co COGS-to-Revenue Chart

Fukuda Denshi Co Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
COGS-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.59 0.58 0.49 0.48 0.47

Fukuda Denshi Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
COGS-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.48 0.44 0.45 0.48 0.50

Fukuda Denshi Co COGS-to-Revenue Calculation

Fukuda Denshi Co's COGS to Revenue for the fiscal year that ended in Mar. 2024 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=65876 / 140323
=0.47

Fukuda Denshi Co's COGS to Revenue for the quarter that ended in Dec. 2023 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=15798 / 32717
=0.48

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Fukuda Denshi Co  (TSE:6960) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Fukuda Denshi Co's Gross Margin % for the three months ended in Dec. 2023 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 15798 / 32717
=51.71 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.


Fukuda Denshi Co COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Fukuda Denshi Co's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Fukuda Denshi Co (TSE:6960) Business Description

Traded in Other Exchanges
N/A
Address
39-4, Hongo 3-chome, Bunkyo-ku, Tokyo, JPN, 113-8483
Fukuda Denshi Co Ltd develops and manufactures medical electronic equipment. The firm operates in four segments: physiological diagnostic equipment, patient monitoring equipment, medical treatment equipment, and consumables and other products. The physiological diagnostic equipment business sells electrocardiographs, vascular screening systems, and blood cell counters. The patient monitoring equipment segment sells patient monitors and transmitters. The medical treatment equipment segment contributes the largest proportion of revenue and sells pacemakers and medical equipment for home treatment. The consumables and other products segment sells disposable electrodes and consumables used for the firm's devices. Fukuda Denshi generates the vast majority of its sales in Japan.

Fukuda Denshi Co (TSE:6960) Headlines

No Headlines